Project

A phase I/II study of individually dose-optimized (dose escalation) bi-daily sc natural ghrelin on safety, toxicity and tolerability, and nutritional intake, physical function, muscle mass, gastrointestinal motility, eating-related symptoms and inflammation

Aborted · 2009 until 2011